Authors: | Bewersdorf, J. P.; Shimony, S.; Shallis, R. M.; Liu, Y.; Berton, G.; Schaefer, E. J.; Zeidan, A. M.; Goldberg, A.; Stein, E.; Marcucci, G.; Bystrom, R. P.; Lindsley, R. C.; Chen, E. C.; Ramos, J.; Stein, A.; Pullarkat, V.; Aldoss, I.; DeAngelo, D. J.; Neuberg, D. S.; Stone, R. M.; Garciaz, S.; Ball, B.; Stahl, M. |
Title: | Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia—A multicenter cohort study |
Keywords: | unclassified drug; gene mutation; overall survival; monotherapy; cytarabine; letter; cohort analysis; cytogenetics; hematopoietic stem cell transplantation; health care quality; multicenter study; daunorubicin; allogeneic hematopoietic stem cell transplantation; therapy effect; molecular biology; protein inhibitor; induction chemotherapy; recurrence free survival; randomized controlled trial (topic); isocitrate dehydrogenase 1; drug; comparative effectiveness; midostaurin; acute myeloid leukemia; intensive induction chemotherapy; gemtuzumab; high throughput sequencing; hypomethylating agent; isocitrate dehydrogenase 2; quizartinib; human; liposomal cytarabine; ozogamicin; venetoclax; protein b cell lymphoma 2 inhibitor |
Journal Title: | American Journal of Hematology |
Volume: | 99 |
Issue: | 8 |
ISSN: | 0361-8609 |
Publisher: | John Wiley & Sons, Inc. |
Date Published: | 2024-08-01 |
Start Page: | 1640 |
End Page: | 1643 |
Language: | English |
DOI: | 10.1002/ajh.27366 |
PUBMED: | 38751104 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PubMed record and PDF -- Source: Scopus |